To The Moon

📊 CPI & PPI Week: Will 25 or 50 bps Break the Stalemate? Markets are kicking off September with tension in the air. This week brings two data bombs — PPI on Wednesday and CPI on Thursday — that could dictate the Fed’s next move. After months of debating whether September means a cautious 25 bps cut or a bold 50 bps slash, investors may finally get their answer. So far, stocks have drifted sideways, bond yields are twitchy, and the dollar is hanging on every inflation whisper. Everyone knows the script: cooler data means the Fed loosens, hotter data means they stay tight. But here’s the twist — what if the numbers do nothing to break the deadlock? --- 🏦 The Fed’s Tightrope Act The Fed is walking a narrow rope, with risk on both sides. On one hand, growth is slowing, credit is tightening

I’d go with Option B—sticking with my main job and building stable income. Predictability and consistency matter more to me than chasing occasional windfalls. Just like dividend investing, the steady flow may look “boring,” but over time, compounding does the heavy lifting and builds lasting wealth. That’s not to say I don’t admire those who go for Option A. Upskilling to take on high-value side gigs can boost income, but it often comes with uncertainty, irregular demand, and physical limits on how much you can handle. In investing terms, it’s like timing volatile trades—you might win big once, but sustaining it is tough. So I prefer focusing on stability while letting my portfolio compound in the background. Dividend reinvestment feels like the “silent worker” that doesn’t need me consta

$Venture(V03.SI)$     Today, she has risen up again and is now trading at 13.70, looks rather bullish likely to rise up further towards 14.00 than 14.15 soon! Pls dyodd. Hosey! Nice breakout at 13.53 and the Gapped has also been covered, this is rather bullish and we may see her rising up further towards 14.00-14.12. Huat ah! https://sporeshare.blogspot.com/2025/09/venture-today-she-has-risen-up-again.html Venture - Nice, the dividend Gapped at 13.53 has been covered. Likely to continue to trend higher! She may rise up to test 14.00 and above. Pls dyodd. 1st September 2025: Price seem to bounce-off from after going XD and is now trading at 13.38, looks rather bullish! She may rise up to cover the dividend Gapped at 13.53. Chiong ah! Pl

Here’s my take on $Figure Technology Solutions (FT Intermediate)(FIGR)$ debut. With strong momentum in blockchain IPOs and Figure’s solid fundamentals — rapid HELOC growth, profitability, and backing from Duquesne Family Office — I expect investors to show strong confidence. Recent debuts like $Bullish(BLSH)$ and $Circle Internet Corp.(CRCL)$ soared triple digits, showing clear appetite for crypto-fintech plays. While Figure may not spike as high, demand should still drive it well above its $20–$22 IPO range. That’s why my prediction for Figure’s first-day close is $55, m

Oracle's $455 Billion AI Bet Puts Cloud Rivals on Notice We have long maintained that the highest return on investment for artificial intelligence will be realized in cloud computing. $Oracle(ORCL)$   , as the first of the "Big Five" cloud giants to report its latest quarterly earnings, has provided a stunning validation of this thesis. Its Oracle Cloud Infrastructure (OCI) posted a staggering 55% growth rate, a figure set to once again lead the global cloud market and which sent its stock soaring in after-hours trading. Let's break down what just happened. Oracle's Monumental Quarter Oracle's results paint a picture of a company firing on all cylinders, rapidly converting AI demand into a massive, tangible

The SPDR S&P Biotech ETF (XBI) draws investors who seek high-risk, high-reward exposure to the biotech sector. In late 2025, investor sentiment remains cautiously optimistic. This reflects both strong opportunities and ongoing uncertainty. Analysts set a 12-month price target near $141.31. That suggests a 48% upside from current levels around $95. Technical indicators support this outlook. Twelve out of seventeen signal “Buy,” and none recommend “Sell.” Still, some analysts urge caution. XBI depends on clinical trials and faces unpredictable earnings. Its volatility requires careful planning and strong risk tolerance. Financial growth prospects for XBI look promising. Macroeconomic trends and biotech advances shape its performance. The industry expects gains from rising healthcare spen

$Oracle(ORCL)$   I'm really excited about Oracle's latest earnings report, especially seeing their stock surge more than 35% in after-hours trading. It's impressive how their AI business is driving this momentum, even if the overall revenue and EPS didn't quite hit the mark. As someone who's been following cloud and AI trends closely, this kind of growth makes me think Oracle is positioning itself as a serious player in the space. The standout figure for me is the 359% year-over-year increase in their contracted but not yet realized revenue, jumping to $455 billion from $138 billion last quarter. That speaks volumes about the demand for Oracle's AI infrastructure and cloud services. It's not just hype; these are

$HSI(HSI)$ The Hang Seng Index (HSI) has reclaimed a level it has not seen since 2021, breaking through the 26,000-point barrier and marking a decisive four-year high. For a market that had been written off by many global investors as “uninvestable,” the rally signals a dramatic shift in sentiment. Not only has the index as a whole gained momentum, but individual constituents are delivering staggering returns. Eleven Hang Seng Index stocks have doubled in value this year, and several blue-chip giants have reclaimed multi-year highs. Tencent closed at HK$633, its strongest level in three years, while NetEase’s U.S.-listed shares reached $145, an all-time record. With China’s tech, consumer, and financial sectors driving the rally, investors are aski

The Hang Seng Index (HSI) has smashed through 26,000 points to 26,150.73, hitting a 4-year high, fueled by a China market resurgence. Tencent closed at HK$633, a 3-year peak with a 51.67% YTD gain, while NetEase (NTES) U.S. shares hit $145, an all-time high with a 38% surge. Standouts include Xiaomi up 62.90%, China Life Insurance up 58.79%, HSBC up 41.67%, Pop Mart up 222.80%, Sino Biopharmaceutical up 181.97%, and Chow Tai Fook Jewellery up 146.39%, with 11 HSI constituents doubling this year. The S&P 500 sits at 6,520.34, Nasdaq at 21,950, and Bitcoin at $123,456, with the VIX at 14.10 and oil at $74.50/barrel amid tariff talks. Posts found on X cheer “China bull run” but flag “overheating risks.” Are you bullish on this record rally? Beyond Alibaba and Tencent, which tech stocks ca

$Oracle(ORCL)$ $GameStop(GME)$ $CME Bitcoin - main 2509(BTCmain)$  ⬇️ Down movers I’m noting $SNPS sliding -35% on weak Q3 results and soft guidance, erasing recent strength. I’m tracking $WOLF down -14% as the Chapter 11 bounce cools. I’m watching $CHWY -14% after beating Q2 revenue but guiding cautiously. ⬆️ Up movers I’m tracking $ORCL +33%+ as AI cloud demand explodes, booking $455B in orders, and pushing trillion-dollar chatter. Shares are pacing for the best rally since 1992, +101% YTD. I’m noting $GME +6% on a Q2 beat, its 5th straight profit, breaking above $24 resistance with the 80-day MA in sight. ⚡ Special catalysts $ORCL dominated midday tap

$Uber(UBER)$ $Joby Aviation, Inc.(JOBY)$ $Tesla Motors(TSLA)$ 🛫🚀🚖 I’m fully convinced we’re witnessing the start of a mobility revolution. Uber isn’t just adding another service line; with Joby’s $125M acquisition of Blade’s passenger business, it’s laying the foundation for an aerial ridesharing ecosystem. Helicopter and seaplane rides will be integrated directly into the Uber app by 2026, and the quiet, zero-emission air taxis that follow could redefine urban transport economics. Joby Aviation ($JOBY) surged +8.6% premarket on this news. After retracing from its $20.04 high, JOBY has compressed near $13.45. Fibonacci retracements off the summer rally put $14.50

Based on the U.S. Producer Price Index (PPI) for August 2025, which was released on September 10, 2025, here are the key signals and their implications: Overall PPI Decline: The headline PPI for final demand declined by 0.1% on a month-over-month (MoM) basis. This was an unexpected and significant shift, as the consensus forecast was for a 0.3% increase. It's the first decline in four months. Core PPI Decline: The "Core PPI," which excludes the volatile food and energy sectors, also fell by 0.1% MoM, missing the forecast of a 0.3% increase. This is a very important signal because it suggests that price pressures are easing across a broader range of goods and services, not just due to fluctuations in food and energy prices. Disinflationary Signal: The unexpected declines in both the headlin

$NVIDIA(NVDA)$ $Broadcom(AVGO)$ $Tesla Motors(TSLA)$ 🚨📉📈 I’m convinced $NVDA is sitting at the edge of a structural shift that will redefine its valuation, its moat, and its trajectory. Spot is trading near $176.50 after testing higher, with $179.90 still the wall of rejection. $176.22 and $175 are critical pivots underneath, while $165 anchors the downside. The question is no longer whether this is a bounce; it’s whether Nvidia is about to be repriced into a new cycle. 📊 Technical chart check: On the 4H and 30m charts, $NVDA is hugging the upper Bollinger and Keltner bands, signaling momentum strength but also highlighting that $179.90 remains the lid. Price has